Arteriosclerosis and Thrombosis, Vol 13, 1412-1417, Copyright © 1993 by American Heart Association

ARTICLES

Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group

M Cortellaro, E Cofrancesco, C Boschetti, L Mussoni, MB Donati, M Cardillo, M Catalano, L Gabrielli, B Lombardi and G Specchia
Istituto di Medicina Interna, University of Milan, Italy.

A case-control comparison within the framework of the prospective, multidisciplinary PLAT Study was performed to assess whether altered baseline fibrinolytic variables were associated with an elevated risk of ischemic thrombotic events in patients with documented coronary, cerebral, and/or peripheral atherosclerotic disease. Fibrinogen, D- dimer, tissue plasminogen activator (t-PA) antigen, and fibrinolytic activity before and after venous stasis (delta = difference between the two values), t-PA inhibitor, and lipid levels in 60 atherosclerotic patients with a thrombotic event during the first year of follow-up were compared with those in 94 atherosclerotic patients without such events, who were matched for age, sex, and diagnosis at enrollment. Events were associated with a higher release of delta t-PA antigen (P = .047), higher D-dimer (P = .024), and higher t-PA inhibitor (P = .001) levels. delta Fibrinolytic activity was correlated inversely with t-PA inhibitor (P < .01) and triglycerides (P < .05). D-Dimer was also correlated with systolic blood pressure (P < .01). Atherosclerotic patients at higher risk of thrombotic ischemic events are characterized by increased fibrin turnover and impaired fibrinolytic activity due to high t-PA inhibitor levels. This hemostatic disequilibrium may participate with conventional risk factors such as elevated triglyceride levels and systolic blood pressure in the multifactorial mechanism of ischemic sequelae in patients with preexisting vascular atherothrombotic disease.

This article has been cited by other articles:

				E.-G. V. Giardina, H. J. Chen, R. R. Sciacca, and L. E. Rabbani Dynamic Variability of Hemostatic and Fibrinolytic Factors in Young Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6179 - 6184. [Abstract] [Full Text] [PDF]

				G.D.O. Lowe, J. Danesh, S. Lewington, M. Walker, L. Lennon, A. Thomson, A. Rumley, and P.H. Whincup Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis Eur. Heart J., February 1, 2004; 25(3): 252 - 259. [Abstract] [Full Text] [PDF]

				R. von Kanel, J. E. Dimsdale, T. L. Patterson, and I. Grant Association of Negative Life Event Stress With Coagulation Activity in Elderly Alzheimer Caregivers Psychosom Med, January 1, 2003; 65(1): 145 - 150. [Abstract] [Full Text] [PDF]

				A.L. Komarov, E.P. Panchenko, A.B. Dobrovolsky, Yu.A. Karpov, A.D. Deev, E.V. Titaeva, K.K. Davletov, A.R. Eshkeeva, and L.A. Markova D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease Eur. Heart J., August 2, 2002; 23(16): 1309 - 1316. [Abstract] [PDF]

				A. W. Gardner and L. A. Killewich Association Between Physical Activity and Endogenous Fibrinolysis in Peripheral Arterial Disease: A Cross-sectional Study Angiology, July 1, 2002; 53(4): 367 - 374. [Abstract] [PDF]

				J. D. Mills, M. W. Mansfield, and P. J. Grant Tissue Plasminogen Activator, Fibrin D-Dimer, and Insulin Resistance in the Relatives of Patients With Premature Coronary Artery Disease Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 704 - 709. [Abstract] [Full Text] [PDF]

				W. Koenig, D. Rothenbacher, A. Hoffmeister, M. Griesshammer, and H. Brenner Plasma Fibrin D-Dimer Levels and Risk of Stable Coronary Artery Disease: Results of a Large Case-Control Study Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1701 - 1705. [Abstract] [Full Text] [PDF]

				R. von Kanel, P. J. Mills, C. Fainman, and J. E. Dimsdale Effects of Psychological Stress and Psychiatric Disorders on Blood Coagulation and Fibrinolysis: A Biobehavioral Pathway to Coronary Artery Disease? Psychosom Med, July 1, 2001; 63(4): 531 - 544. [Abstract] [Full Text] [PDF]

				P. Bogaty, P. Poirier, S. Simard, L. Boyer, S. Solymoss, and G. R. Dagenais Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina Circulation, June 26, 2001; 103(25): 3062 - 3068. [Abstract] [Full Text] [PDF]

				G. D. O. Lowe, J. W. G. Yarnell, A. Rumley, D. Bainton, and P. M. Sweetnam C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study : Are Inflammation and Fibrin Turnover Linked in Pathogenesis? Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 603 - 610. [Abstract] [Full Text] [PDF]

				D. T. Eitzman, R. J. Westrick, Z. Xu, J. Tyson, and D. Ginsburg Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery Blood, December 15, 2000; 96(13): 4212 - 4215. [Abstract] [Full Text] [PDF]

				G. Y. H. Lip and A. D. Blann Thrombogenesis and fibrinolysis in acute coronary syndromes: Important facets of a prothrombotic or hypercoagulable state? J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2044 - 2046. [Full Text] [PDF]

				A. Sonel, B. M. Sasseen, N. Fineberg, N. Bang, and R. L. Wilensky Prospective Study Correlating Fibrinopeptide A, Troponin I, Myoglobin, and Myosin Light Chain Levels With Early and Late Ischemic Events in Consecutive Patients Presenting to the Emergency Department With Chest Pain Circulation, September 5, 2000; 102(10): 1107 - 1113. [Abstract] [Full Text] [PDF]

				B. Wiman, T. Andersson, J. Hallqvist, C. Reuterwall, A. Ahlbom, and U. deFaire Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 2019 - 2023. [Abstract] [Full Text] [PDF]

				S. Ren, S. Shatadal, and G. X. Shen Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E656 - E662. [Abstract] [Full Text] [PDF]

				H. Sjoland, D. T. Eitzman, D. Gordon, R. Westrick, E. G. Nabel, and D. Ginsburg Atherosclerosis Progression in LDL Receptor-Deficient and Apolipoprotein E-Deficient Mice Is Independent of Genetic Alterations in Plasminogen Activator Inhibitor-1 Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 846 - 852. [Abstract] [Full Text] [PDF]

				G. W. de Valk-de Roo, C. D.A. Stehouwer, P. Meijer, V. Mijatovic, C. Kluft, P. Kenemans, F. Cohen, S. Watts, and C. Netelenbos Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women : A 2-Year, Placebo-Controlled Study Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2993 - 3000. [Abstract] [Full Text] [PDF]

				K. Kunz, P. Petitjean, M. Lisri, F. Chantrel, C. Koehl, M.-L. Wiesel, J.-P. Cazenave, B. Moulin, and T. P. Hannedouche Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1934 - 1942. [Abstract] [Full Text] [PDF]

				M. Nauck, H. Wieland, and W. Marz Rapid, Homogeneous Genotyping of the 4G/5G Polymorphism in the Promoter Region of the PAI1 Gene by Fluorescence Resonance Energy Transfer and Probe Melting Curves Clin. Chem., August 1, 1999; 45(8): 1141 - 1147. [Abstract] [Full Text] [PDF]

				G. W. de Valk-de Roo, C. D.A. Stehouwer, J. Lambert, C. G. Schalkwijk, M. J. van der Mooren, C. Kluft, and C. Netelenbos Plasma Homocysteine Is Weakly Correlated with Plasma Endothelin and von Willebrand Factor but not with Endothelium-dependent Vasodilatation in Healthy Postmenopausal Women Clin. Chem., August 1, 1999; 45(8): 1200 - 1205. [Abstract] [Full Text] [PDF]

				M. A Ferguson, B. Gutin, S. Owens, P. Barbeau, R. P Tracy, and M. Litaker Effects of physical training and its cessation on the hemostatic system of obese children Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1130 - 1134. [Abstract] [Full Text] [PDF]

				M. Cesari and G. P. Rossi Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1378 - 1386. [Full Text] [PDF]

				B. A. Allison, L. Nilsson, F. Karpe, A. Hamsten, and P. Eriksson Effects of Native, Triglyceride-Enriched, and Oxidatively Modified LDL on Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1354 - 1360. [Abstract] [Full Text] [PDF]

				M. Cushman, R. N. Lemaitre, L. H. Kuller, B. M. Psaty, E. M. Macy, A. R. Sharrett, and R. P. Tracy Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly : The Cardiovascular Health Study Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 493 - 498. [Abstract] [Full Text] [PDF]

				P. A. Sakkinen, M. Cushman, B. M. Psaty, B. Rodriguez, R. Boineau, L. H. Kuller, and R. P. Tracy Relationship of Plasmin Generation to Cardiovascular Disease Risk Factors in Elderly Men and Women Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 499 - 504. [Abstract] [Full Text] [PDF]

				N. Marx, T. Bourcier, G. K. Sukhova, P. Libby, and J. Plutzky PPAR{gamma} Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression : PPAR{gamma} as a Potential Mediator in Vascular Disease Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 546 - 551. [Abstract] [Full Text] [PDF]

				B. Kristensen, J. Malm, T. K. Nilsson, J. Hultdin, B. Carlberg, and T. Olsson Increased Fibrinogen Levels and Acquired Hypofibrinolysis in Young Adults With Ischemic Stroke Stroke, November 1, 1998; 29(11): 2261 - 2267. [Abstract] [Full Text] [PDF]

				C. A. DeSouza, P. P. Jones, and D. R. Seals Physical Activity Status and Adverse Age-Related Differences in Coagulation and Fibrinolytic Factors in Women Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 362 - 368. [Abstract] [Full Text] [PDF]

				P. Mustonen, M. Lepantalo, and R. Lassila Physical Exertion Induces Thrombin Formation and Fibrin Degradation in Patients With Peripheral Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 244 - 249. [Abstract] [Full Text] [PDF]

				P. Eriksson, L. Nilsson, F. Karpe, and A. Hamsten Very-Low-Density Lipoprotein Response Element in the Promoter Region of the Human Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Hypertriglyceridemia Arterioscler Thromb Vasc Biol, January 1, 1998; 18(1): 20 - 26. [Abstract] [Full Text] [PDF]

				B. D. Spiess Endothelial Cell-Blood Interface Actions and the Procoagulant Response Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 288 - 294. [Abstract] [PDF]

				Y. Hong, N. L. Pedersen, N. Egberg, and U. de Faire Moderate Genetic Influences on Plasma Levels of Plasminogen Activator Inhibitor-1 and Evidence of Genetic and Environmental Influences Shared by Plasminogen Activator Inhibitor-1, Triglycerides, and Body Mass Index Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2776 - 2782. [Abstract] [Full Text]

				D. J. Schneider, M. A. Ricci, D. J. Taatjes, P. Q. Baumann, J. C. Reese, B. J. Leavitt, P. M. Absher, and B. E. Sobel Changes in Arterial Expression of Fibrinolytic System Proteins in Atherogenesis Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3294 - 3301. [Abstract] [Full Text]

				B. Fernhall, L. M. Szymanski, P. A. Gorman, J. Milani, D. C. Paup, and C. M. Kessler Fibrinolytic Activity Is Similar in Physically Active Men With and Without a History of Myocardial Infarction Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1106 - 1113. [Abstract] [Full Text]

				C. Held, P. Hjemdahl, N. Rehnqvist, N. H. Wallen, I. Bjorkander, S. V. Eriksson, L. Forslund, and B. Wiman Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or Metoprolol: Results From the Angina Prognosis Study in Stockholm Circulation, May 20, 1997; 95(10): 2380 - 2386. [Abstract] [Full Text]

				K. K. Koh, R. Mincemoyer, M. N. Bui, G. Csako, F. Pucino, V. Guetta, M. Waclawiw, and R. O. Cannon Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women N. Engl. J. Med., March 6, 1997; 336(10): 683 - 691. [Abstract] [Full Text] [PDF]

				P. M. Ridker, C. H. Hennekens, K. Lindpaintner, M. J. Stampfer, and J. P. Miletich Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US Men Circulation, January 7, 1997; 95(1): 59 - 62. [Abstract] [Full Text]

				V. A. Carroll, M. R. Griffiths, M. Geiger, C. Merlo, M. Furlan, B. Lammle, and B. R. Binder Plasma Protein C Inhibitor Is Elevated in Survivors of Myocardial Infarction Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 114 - 118. [Abstract] [Full Text]

				I. Juhan-Vague, S. D.M. Pyke, M. C. Alessi, J. Jespersen, F. Haverkate, and S. G. Thompson Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris Circulation, November 1, 1996; 94(9): 2057 - 2063. [Abstract] [Full Text]

				E. Shahar, A. R. Folsom, V. V. Salomaa, V. L. Stinson, P. G. McGovern, T. Shimakawa, L. E. Chambless, and K. K. Wu Relation of Hormone-Replacement Therapy to Measures of Plasma Fibrinolytic Activity Circulation, June 1, 1996; 93(11): 1970 - 1975. [Abstract] [Full Text]

				A. Broijersen, M. Eriksson, B. Wiman, B. Angelin, and P. Hjemdahl Gemfibrozil Treatment of Combined Hyperlipoproteinemia : No Improvement of Fibrinolysis Despite Marked Reduction of Plasma Triglyceride Levels Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 511 - 516. [Abstract] [Full Text]

				W. L. Chandler, W. C. Levy, and J. R. Stratton The Circulatory Regulation of TPA and UPA Secretion, Clearance, and Inhibition During Exercise and During the Infusion of Isoproterenol and Phenylephrine Circulation, November 15, 1995; 92(10): 2984 - 2994. [Abstract] [Full Text]

				J. Amiral State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 243 - 259. [Abstract] [PDF]

				A. Hamsten Hemostatic Function and Coronary Artery Disease N. Engl. J. Med., March 9, 1995; 332(10): 677 - 678. [Full Text]

				J. D. Mills, M. W. Mansfield, and P. J. Grant Tissue Plasminogen Activator, Fibrin D-Dimer, and Insulin Resistance in the Relatives of Patients With Premature Coronary Artery Disease Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 704 - 709. [Abstract] [Full Text] [PDF]